Treatment Outcomes Stratified by Baseline Immunological Status among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings

Abstract
A study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor—based antiretroviral therapy in resource-limited